ATE372769T1 - Injizierbare galenische formulierung zur verwendung in einer photodynamischen diagnose oder therapie sowie ihr herstellungsverfahren - Google Patents

Injizierbare galenische formulierung zur verwendung in einer photodynamischen diagnose oder therapie sowie ihr herstellungsverfahren

Info

Publication number
ATE372769T1
ATE372769T1 AT02747627T AT02747627T ATE372769T1 AT E372769 T1 ATE372769 T1 AT E372769T1 AT 02747627 T AT02747627 T AT 02747627T AT 02747627 T AT02747627 T AT 02747627T AT E372769 T1 ATE372769 T1 AT E372769T1
Authority
AT
Austria
Prior art keywords
photosensitizer
therapy
production
photodynamic diagnosis
galenic formulation
Prior art date
Application number
AT02747627T
Other languages
English (en)
Inventor
Pierre-Herve Brun
Alain Prudhomme
Jean-Luc Barnoux
Original Assignee
Steba Biotech N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steba Biotech N V filed Critical Steba Biotech N V
Application granted granted Critical
Publication of ATE372769T1 publication Critical patent/ATE372769T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02747627T 2001-07-17 2002-07-05 Injizierbare galenische formulierung zur verwendung in einer photodynamischen diagnose oder therapie sowie ihr herstellungsverfahren ATE372769T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01810708A EP1277470A1 (de) 2001-07-17 2001-07-17 Injizierbare galenische Zubereitung zur Anwendung in einer photodynamischen Therapie oder Diagnose und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE372769T1 true ATE372769T1 (de) 2007-09-15

Family

ID=8184036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747627T ATE372769T1 (de) 2001-07-17 2002-07-05 Injizierbare galenische formulierung zur verwendung in einer photodynamischen diagnose oder therapie sowie ihr herstellungsverfahren

Country Status (20)

Country Link
US (1) US20040147500A1 (de)
EP (2) EP1277470A1 (de)
JP (1) JP2004537562A (de)
CN (1) CN1303999C (de)
AT (1) ATE372769T1 (de)
BR (1) BR0211173A (de)
CA (1) CA2454150A1 (de)
DE (1) DE60222421T2 (de)
DK (1) DK1406616T3 (de)
ES (1) ES2292781T3 (de)
HU (1) HUP0400754A3 (de)
IL (1) IL159620A0 (de)
MX (1) MXPA04000042A (de)
NO (1) NO20040216L (de)
NZ (1) NZ530634A (de)
PL (1) PL368503A1 (de)
PT (1) PT1406616E (de)
RU (1) RU2278665C2 (de)
WO (1) WO2003009842A1 (de)
ZA (1) ZA200400328B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
KR100866728B1 (ko) * 2004-11-12 2008-11-03 주식회사종근당 타크로리무스를 함유하는 주사제
EP2008665A1 (de) * 2007-06-25 2008-12-31 Steba Biotech N.V. Injizierbare Formulierung für die photodynamische Therapie
RU2565766C1 (ru) * 2014-11-17 2015-10-20 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Л. Гольдберга" 4-(3,4-дибромтиофенкарбонил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекан в качестве анальгетического средства и способ его получения
ES2895851T3 (es) * 2016-04-01 2022-02-22 Trioptotec Gmbh Dispersión de fotosensibilizador y uso de la misma
CN108670950B (zh) * 2018-06-29 2020-10-02 深圳海王医药科技研究院有限公司 一种不含有机溶剂的虎杖苷药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2963178B2 (ja) * 1990-09-27 1999-10-12 株式会社エス・エル・ティ・ジャパン 水溶性フェオホーバイドａの製造方法
US5654423A (en) * 1990-11-21 1997-08-05 Regents Of The University Of California Boronated metalloporphyrine and therapeutic methods
JPH08505054A (ja) * 1992-12-23 1996-06-04 アイオア ステート ユニバーシティー リサーチ ファンデーション インコーポレーテッド 分子フラッシュ
US6147195A (en) * 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US5462726A (en) * 1993-12-17 1995-10-31 Bristol-Myers Squibb Company Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
RU2144085C1 (ru) * 1996-07-12 2000-01-10 Московская государственная академия тонкой химической технологии им.М.В.Ломоносова Способ получения бактериохлорофилла а
EP1137411B1 (de) * 1998-12-09 2006-12-06 YEDA RESEARCH AND DEVELOPMENT Co. LTD. Palladiumsubstituierte bakteriochlorophyllderivate und deren verwendung

Also Published As

Publication number Publication date
WO2003009842A8 (fr) 2004-04-01
PL368503A1 (en) 2005-04-04
JP2004537562A (ja) 2004-12-16
EP1277470A1 (de) 2003-01-22
DE60222421T2 (de) 2008-06-05
ZA200400328B (en) 2004-09-13
ES2292781T3 (es) 2008-03-16
EP1406616B1 (de) 2007-09-12
MXPA04000042A (es) 2005-08-16
WO2003009842A1 (fr) 2003-02-06
BR0211173A (pt) 2004-08-10
US20040147500A1 (en) 2004-07-29
CA2454150A1 (fr) 2003-02-06
CN1303999C (zh) 2007-03-14
RU2004104469A (ru) 2005-04-20
CN1529594A (zh) 2004-09-15
HUP0400754A3 (en) 2005-11-28
RU2278665C2 (ru) 2006-06-27
NO20040216L (no) 2004-03-17
HUP0400754A2 (hu) 2004-07-28
NZ530634A (en) 2006-11-30
IL159620A0 (en) 2004-06-01
DK1406616T3 (da) 2008-01-21
DE60222421D1 (de) 2007-10-25
EP1406616A1 (de) 2004-04-14
PT1406616E (pt) 2007-12-20

Similar Documents

Publication Publication Date Title
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
EP0501975A4 (en) Antihypertensive compositions and use thereof
WO2005011653A3 (en) Pyridazine derivatives and their use as therapeutic agents
LV12634A (lv) Watersoluble azole antifungals
ATE372769T1 (de) Injizierbare galenische formulierung zur verwendung in einer photodynamischen diagnose oder therapie sowie ihr herstellungsverfahren
DE69015736D1 (de) 7-Keto- und 7-Hydroxy-androsta-3,5-dien-3-carbonsäure Derivate.
IL158155A (en) Use of erythropoietin for the preparation of a medicament to ameliorate chemotherapy-induced toxicity
IL169257A0 (en) Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents
EP1555266A4 (de) Heilmittel bzw. prophylaktika f r harnfrequenz bzw. harninkontinenz und morphinanderivate mit stickstoffhaltiger heterocyclischer gruppe
DE69223736D1 (de) Acridine-1,8-Dionderivate als therapeutisches Mittel
DE60215313D1 (de) Indolderivate und deren verwendung als gnrh antagonisten
ATE156119T1 (de) 2-formylpyridin-thiosemicarbazonderivate, ihre herstellung und ihre verwendung als antitumor mittel
BR0214256A (pt) Medicamento e uso do mesmo
GR3003232T3 (en) Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel
WO2003026570A3 (en) Reduced toxicity cisplatin formulations and methods for using the same
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
TR199801398T2 (xx) Ast�m� tedavi edici maddeler
DE69837219D1 (de) 1,4,7,10-tetraazacyclododecan-1,4-diessigsäure
WO2003013380A3 (en) Multi-part dental bleaching systems and method for bleaching teeth using such systems
EP2266566A3 (de) Nicotinamid Derivate und ihrer Verwendung als Therapeutika
ZA986334B (en) Medicaments comprising a polyhydroxyalkylpyrazine derivative novel derivatives and their preparation
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
EP0417209A4 (en) Compositions and methods for administering therapeutically active compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1406616

Country of ref document: EP

REN Ceased due to non-payment of the annual fee